BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/11/2015 10:03:00 AM | Browse: 722 | Download: 1939
Publication Name World Journal of Diabetes
Manuscript ID 19786
Country United Kingdom
Received
2015-05-21 08:42
Peer-Review Started
2015-05-21 17:28
First Decision by Editorial Office Director
Return for Revision
2015-09-17 16:30
Revised
2015-09-25 17:51
Publication Fee Transferred
Second Decision by Editor
2015-10-14 17:30
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2015-10-27 17:34
Articles in Press
2015-10-27 17:34
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-10-30 08:36
Publish the Manuscript Online
2015-11-11 10:00
ISSN 1948-9358 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Review
Article Title New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders
Manuscript Source Invited Manuscript
All Author List Nigel Irwin and Peter R Flatt
Funding Agency and Grant Number
Corresponding Author Dr. Nigel Irwin, SAAD Centre for Pharmacy and Diabetes, University of Ulster, Cromore Road, Coleraine BT52 1SA, Northern Ireland, United Kingdom. n.irwin@ulster.ac.uk
Key Words Diabetes; Obesity; Incretin; Prediabetes; Gut hormones
Core Tip Stable gut hormones have well defined thera?peutic actions for type 2 diabetes mellitus. In addition, simultaneous modulation of gut hormone receptors could increase therapeutic efficacy, but timing and receptor activation profile may be important. Finally, gut-derived peptides could possess benefits for bone disorders, cognitive impairment and cardiovascular dysfunction.
Publish Date 2015-11-11 10:00
Citation Irwin N, Flatt PR. New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders. World J Diabetes 2015; 6(15): 1285-1295
URL http://www.wjgnet.com/1948-9358/full/v6/i15/1285.htm
DOI http://dx.doi.org/10.4239/wjd.v6.i15.1285
Full Article (PDF) WJD-6-1285.pdf
Full Article (Word) WJD-6-1285.doc